Top Markets
Coin of the day
Augmedix, Inc. Augmedix, Inc.

Augmedix, Inc.

AUGX
Rank in Stocks #22478
Augmedix, Inc. is a U.S.-based company specializing in remote medical... Augmedix, Inc. is a U.S.-based company specializing in remote medical documentation and offering live support to clinical professionals. Its comprehensive platform, comprising Augmedix Live and Augmedix Notes, streamlines the entire documentation process for patient encounters. This includes preparatory tasks like pre-charting and digitizing historical patient data prior to appointments. During the consultation, it generates essential medical notes, flags care gaps, provides HCC reminders, and produces after-visit summaries. Post-visit, the system facilitates crucial administrative duties such as medical coding, processing orders, and managing referrals. Clinicians can readily access these applications via mobile devices, including smartphones or specialized wearables like Google Glass. The company's clientele primarily consists of various health systems and distinct specialty groups. Founded in 2013, Augmedix maintains its corporate headquarters in San Francisco, California.
Share Price
$2.35
Last synced: 2024-10-02
Market Cap
$87.95M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Augmedix, Inc. (AUGX)

Category

Earnings for Augmedix, Inc. (AUGX)
Earnings in Jun 2024 TTM: $-23.87M
According to Augmedix, Inc. latest financial reports the company's current earnings are $-23.87M. In 2022 the company made an earning of $-24.45M, a decrease compared to its 2021 earnings that were of $-17.85M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Augmedix, Inc. from 2018 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $-23.87M 25.43%
2023 $-19.03M -22.18%
2022 $-24.45M 36.96%
2021 $-17.85M 14.40%
2020 $-15.60M -15.65%
2019 $-18.50M -23.44%
2018 $-24.16M 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$2.04B -8,660.65%
US
$266.26M -1,215.68%
AU
$-259.89M 989.02%
US
$295.53M -1,338.35%
US
- -
US